Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Angiotensin receptor blockers and β-blockers in Marfan syndrome: an individual-patient-data meta-analysis of randomised trials

EMBERSON J. et al, (2022), The Lancet

Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes

EMBERSON J. et al, (2022), Nature Communications

Genotyping, sequencing and analysis of 140,000 adults from the Mexico City Prospective Study

Ziyatdinov A. et al, (2022)

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

LANDRAY M. et al, (2022), The Lancet

Body mass index and COVID-19 mortality: prospective study of 120,000 Mexican adults

EMBERSON J. et al, (2022), International Journal of Epidemiology

Harmonization of large-scale, heterogeneous individual participant adverse event data from randomized trials of statin therapy

EMBERSON J. et al, (2022), Clinical Trials

Allocated but not treated: the silent 16%

Horby P. et al, (2022), LANCET, 399, 1776 - 1776

Allocated but not treated: the silent 16% - Authors' reply.

Horby P. et al, (2022), Lancet, 399, 1775 - 1776

Predictive value of circulating NMR metabolic biomarkers for type 2 diabetes risk in the UK Biobank study

BRAGG F. et al, (2022), BMC Medicine

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

RECOVERY Collaborative Group None. et al, (2022)

Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial

HERRINGTON W., (2022), Nephrology, Dialysis and Transplantation

CALIBRATING CARDIOVASCULAR DISEASE POLICY MODEL USING LARGE COHORT DATA

Wu R. et al, (2022), VALUE IN HEALTH, 25, S16 - S16

Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry

Bohbot Y. et al, (2022), European Journal of Heart Failure

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

LANDRAY M. et al, (2021), The Lancet

Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trials

Staplin N. et al, (2021), EClinicalMedicine, 41, 101163 - 101163

Association of Smoking Initiation and Cessation Across the Life Course and Cancer Mortality: Prospective Study of 410 000 US Adults.

Thomson B. et al, (2021), JAMA Oncol

Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Horby PW. et al, (2021), Lancet Respiratory Medicine, 9, 1419 - 1426

Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non-inferiority trial

Al-Shahi Salman R. et al, (2021), The Lancet Neurology, 20, 842 - 853

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

LANDRAY M. et al, (2021), The Lancet

Association of kidney function with NMR-quantified lipids, lipoproteins, and metabolic measures in Mexican adults

Aguilar-Ramirez D. et al, (2021), Journal of Clinical Endocrinology and Metabolism

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?